Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sparta develops new formulations of taxanes

April 5, 1996

Roussel Morishita reports new aromatase inhibitor

April 5, 1996

Boehringer Mannheim synthesizes antitumor anthrapyrazoles

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

Sparta to develop new camptothecin formulations

April 5, 1996

New daunorubicin derivative from P&U

April 5, 1996

Spartaject busulfan to enter phase I

April 5, 1996

FDA approves expanded labeling for Ethyol

March 15, 1996

Multidrug resistance modulator from Pfizer

March 15, 1996

Xenova to evaluate MDR modulator in phase I

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...